BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5554761)

  • 1. [Use of calcium heparinate in anticoagulant therapy].
    Vivien P; Allannic H; Loussouarn J; Turpin J
    Therapie; 1971; 26(1):141-8. PubMed ID: 5554761
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant treatment with heparin].
    Langer B; Wolosker M; Albers MT
    Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolonged anticoagulant treatment by subcutaneous injections of calcium heparinate].
    Demange J; Renais J; Scebat L; Lenegre J
    Presse Med (1893); 1967 Jun; 75(29):1499-502. PubMed ID: 6026886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
    Sessner HH; Brockhaus W; Kunzmann G; Stingl J
    Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin].
    Aiach M; Fiessinger JN; Chousterman M
    Rev Prat; 1977 Dec; 27(57):3953-74. PubMed ID: 345399
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value and practical management of anticoagulant therapy by subcutaneous injection of concentrated calcium heparinate].
    Di Matteo J; Picard R; Cornu P; Vacheron A; Bousquet O
    Arch Mal Coeur Vaiss; 1968 May; 61(5):724-34. PubMed ID: 4971372
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of anticoagulant therapy.
    Ellison N; Jobes DR; Schwartz AJ
    Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142
    [No Abstract]   [Full Text] [Related]  

  • 8. [Subcutaneous calcium heparinate: a new heparin].
    Desrochers Y
    Union Med Can; 1975 May; 104(5):722-8. PubMed ID: 1136066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Remarks on the use of Ca heparinate by subcutaneous route in anticoagulant therapy].
    Vivien P
    Phlebologie; 1973; 26(1):15-21. PubMed ID: 4724445
    [No Abstract]   [Full Text] [Related]  

  • 10. [Control of subcutaneous calcium-heparin therapy by the thrombodensitogram].
    Porta A; Magni S; Camagna P; Donati M; Dinelli CA
    Minerva Med; 1985 Mar; 76(11):531-2. PubMed ID: 3982692
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of heparin therapy: sensitivity of the various methods].
    Merino J; González-Boullosa R; Benet I; García-Conde J
    Rev Clin Esp; 1978 Oct; 151(2):107-11. PubMed ID: 740979
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of heparin and fibrinolysin in patients with coronary arteriosclerosis].
    Aleĭnikova LI
    Vrach Delo; 1966 Mar; 3():53-6. PubMed ID: 4230197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical management of transcutaneous heparin therapy with concentrated calcium heparinate in the treatment and prevention of postoperativve thromboembolic disease].
    Favre J; Schvingt E; Hollender LF
    Lyon Chir; 1971; 67(2):147-50. PubMed ID: 5557694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic heparinization by subcutaneous route with individualized adjustment of the injected dose and of the time schedule of administration].
    Langer B; Montagnini AL; Kutner JM; Khoury V; Albers MT; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):35-9. PubMed ID: 6484439
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of subcutaneous calcium heparin therapy in the treatment of thrombo-embolic disease.
    Hirsh J; O'Sullivan EF; Gallus AS; Martin M
    Med J Aust; 1970 Jan; 1(1):15-7. PubMed ID: 5436524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Revival of heparin therapy (role of calcium heparinate administered intracutaneously].
    Larcan A; Raby C; Streiff F; Calamai M; Alexandre P
    Presse Med (1893); 1968 Jan; 76(2):67-70. PubMed ID: 5638159
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for administering heparin.
    Thurber CF
    J Maine Med Assoc; 1974 Sep; 65(9):212-3. PubMed ID: 4413614
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 19. [The biologic control of long-term heparin therapy in the light of 115 cases of patients treated with subcutaneous calcium heparinate].
    Migne J; Monteil R
    Angeiologie; 1967; 19(5):27-31. PubMed ID: 5621969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of various methods of heparin treatment].
    Chojnowski K; Judkiewicz L; Ciszewski R; Majda J
    Pol Tyg Lek; 1985 Nov; 40(44):1232-4. PubMed ID: 3911186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.